News
Inseego Corp. Statement on Infrastructure Investment and Jobs Act
Inseego Corp. (Nasdaq: INSG), a leader of 5G and intelligent IoT device-to-cloud solutions for enterprises and consumers, congratulates the U.S. Congress and President Joseph R. Biden for a
Victory Capital Announces Pricing of $505 Million Incremental Term Loan Facility to Fund WestEnd Advisors Acquisition
Victory Capital Holdings, Inc. (NASDAQ: VCTR) (“Victory Capital” or the “Company”) today announced that it has successfully completed the syndication of a $505 million Incremental Term Loan
State Street Collateral+ Delivers New Analytics and Optimization Capabilities in Partnership with Cassini Systems
State Street Corporation (NYSE:STT) announced today it has added market leading pre-and post-trade optimization and margin analytics capabilities to its Collateral+ service. In partnership with
Novocure Announces Last Patient Enrolled in Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-small Cell Lung Cancer
Novocure (NASDAQ: NVCR) today announced that the final patient has been enrolled in the phase 3 pivotal LUNAR trial evaluating the efficacy of Tumor Treating Fields (TTFields) together with immune
Deciphera Receives European Commission Approval of QINLOCK® for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today announced that the
Philip Morris International’s ESG Performance Recognized by S&P Dow Jones Indices; Company Included in Dow Jones Sustainability Index North America for Second Consecutive Year
Philip Morris International Inc. (PMI) (NYSE: PM) has been included for the second consecutive year in the Dow Jones Sustainability Index (DJSI) North America. The index recognizes the top 20
American Equity Advances Return of Capital to Shareholders
American Equity Investment Life Holding Company (“American Equity”) (NYSE: AEL), a leading provider of financial dignity solutions through general account annuities, announced today that its Board
Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
Pfizer Inc. (NYSE:PFE) and BioNTech SE (Nasdaq:BNTX) today announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals 12 through 15
Mannatech Declares Special 2021 Dividend
Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend
Victory Capital Stockholders Approve Elimination of Dual-Class Share Structure
Victory Capital Holdings, Inc. (NASDAQ: VCTR) (“Victory Capital” or the “Company”) today announced that its stockholders approved the Company’s previously announced proposal (the “Proposal”) to
E-Auto-Boom lässt Aktien explodieren! (Tesla, BYD, Rivian, Nio, VW)
Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, and Zenas
Puma Biotechnology Presents Data from the Neratinib Arm of the INSIGhT Trial at the 2021 SNO Annual Meeting
Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that investigators presented results from the neratinib arm of the Phase II Individualized Screening Trial of
PLUG POWER INC.- Technical Analysis
.png?locale=us "FinanceClub_UoM")
Quidel Presents at 33rd Annual Piper Sandler Healthcare Conference
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it participated in a
Xencor to Present at Upcoming Investor Conferences
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced
Morgan Stanley Announces Redemption in Whole of Series H Preferred Stock and Depositary Shares Representing Series H Preferred Stock
Morgan Stanley today announced that it will redeem in whole its outstanding Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series H, liquidation preference $25,000 per share (61761J208)
Institutional Property Advisors Brokers Suburban Salt Lake City Multifamily Asset Sale
Institutional Property Advisors (IPA), a division of Marcus & Millichap (NYSE: MMI), announced today the sale of Incline at Anthem, a 298-unit, age 55-plus multifamily complex in Herriman, Utah.
48th Consecutive Year of Dividend Increases for United Bankshares, Inc.
United Bankshares, Inc. (“United”) (NASDAQ: UBSI) today announced that its Board of Directors declared a fourth quarter dividend of $0.36 per share for shareholders of record as of December 2
US Foods to Participate in the Barclays Eat, Sleep, Play Conference on December 1, 2021
US Foods Holding Corp. (NYSE: USFD) Chairman and Chief Executive officer, Pietro Satriano, and Chief Financial Officer, Dirk Locascio, will participate in a fireside chat and provide a general
Fluor Joint Venture Reaches Milestone with Completion of Bypass Structure as Part of Chicago Transit Authority’s Red and Purple Modernization Program
Fluor Corporation (NYSE: FLR) announced today that its joint venture team with Walsh Construction Company has reached the first major milestone of the Chicago Transit Authority’s (CTA) historic Red
Institutional Property Advisors Brokers 10 Class A Multifamily Property Sales in San Antonio for $568.45 Million
Institutional Property Advisors (IPA), a division of Marcus & Millichap (NYSE: MMI), announced today the sale of 10 multifamily assets totaling 2,290 units in San Antonio, Texas over 10 weeks. The
Piper Sandler Companies Announces Share Repurchase Authorization
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, announced today that its board of directors has authorized the repurchase of up to $150 million of the company's outstanding common
Puma Biotechnology to Present Neratinib Data at the San Antonio Breast Cancer Symposium (SABCS)
Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced the release of 9 abstracts that will be presented at the 2021 San Antonio Breast Cancer Symposium (SABCS), to be held
Fifth Third Bancorp 2020 Environmental, Social and Governance Report Earns Five MarCom Awards
Fifth Third Bancorp (Nasdaq: FITB) today announced that its 2020 Environmental, Social and Governance Report, published in June 2021, has earned five MarCom Awards. The 2020 ESG Report won platinum